Journals / The Anatolian Journal of Cardiology / 2016 / Cilt: 16 - Sayı: 7

The use of pre-test and post-test probability values as criteria before selecting patients to undergo coronary angiography in patients who have ischemic findings on myocardial perfusion scintigraphy

Pages
512–519
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The ROC analysis provided a cut-off value of 80.4% for postMPS probability in predicting CAS with 67.9% sensitivity and 77.8% specificity.Conclusion: When the post-MPS probability is >=80% in patients who have reversible perfusion defects on MPS, we suggest interpreting the MPS as "high probability positive" to improve the selection of true-positive patients to undergo CA, and these patients should be primarily recommended CA.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Myocardial perfusion scintigraphy (MPS) is a diagnostic test which is frequently used in the diagnosis of coronary heart disease (CHD).
📊
Key Findings & Data:Between January 2008 and July 2011, 139 patients with positive MPS results and followed by CA recently (<6 months) were evaluated from patient files.
💡
Conclusion & Impact:The ROC analysis provided a cut-off value of 80.4% for postMPS probability in predicting CAS with 67.9% sensitivity and 77.8% specificity.Conclusion: When the post-MPS probability is >=80% in patients who have reversible perfusion defects on MPS, we suggest interpreting the MPS as "high probability positive" to improve the selection of true-positive patients to undergo CA, and these patients should be primarily recommended CA.
🔬Design:Research Article
📍Scope:2008 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Myocardial perfusion scintigraphy (MPS) is a diagnostic test which is frequently used in the diagnosis of coronary heart disease (CHD). MPS is generally interpreted as ischemia present or absent; however, it has a power in predicting the disease, similar to other diagnostic tests. In this study, we aimed to assist in directing the high-risk patients to undergo coronary angiography (CA) primarily by evaluating patients without prior CHD history with pre-test and post-test probabilities. Methods: The study was designed as a retrospective study. Between January 2008 and July 2011, 139 patients with positive MPS results and followed by CA recently (<6 months) were evaluated from patient files. Patients' pre-test probabilities based on the Diamond and Forrester method and the likelihood ratios that were obtained from the literature were used to calculate the patients' post-exercise and post-MPS probabilities. Patients were evaluated in risk groups as low, intermediate, and high, and an ROC curve analysis was performed for the post-MPS probabilities.Results: Coronary artery stenosis (CAS) was determined in 59 patients (42.4%). A significant difference was determined between the risk groups according to CAS, both for the pre-test and post-test probabilities (p<0.001, p=0.024). The ROC analysis provided a cut-off value of 80.4% for postMPS probability in predicting CAS with 67.9% sensitivity and 77.8% specificity.Conclusion: When the post-MPS probability is >=80% in patients who have reversible perfusion defects on MPS, we suggest interpreting the MPS as "high probability positive" to improve the selection of true-positive patients to undergo CA, and these patients should be primarily recommended CA.

🔖

Cite This Article

ŞEN, N. P. K., BEKİŞ, R., CEYLAN, A., DEREBEK, E. (2016). The use of pre-test and post-test probability values as criteria before selecting patients to undergo coronary angiography in patients who have ischemic findings on myocardial perfusion scintigraphy. The Anatolian Journal of Cardiology, Cilt: 16 - Sayı: 7, 512–519. https://ajindex.com/articles/365872

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med 1979; 300: 1350-8
  2. Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and the management of patients with stable ischemic heart disease: a report of American College of Cardiology foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society For Cardiovascular Angiography And Interventions, and Society of Thoracic Surgeons. Circulation 2012; 126: e354-471
  3. Noto TJ Jr, Johnson LW, Krone R, Weaver WF, Clark DA, Kramer JR Jr, et al. Cardiac catheterization 1990: a report of the Registry of the Society for Cardiac Angiography and Interventions (SCA&I). Cathet Cardiovasc Diagn 1991; 24: 75-83
  4. Detrano R, Yiannikas J, Salcedo EE, Rincon G, Go RT, Williams G, et al. Bayesian probability analysis: a prospective demonstration of its clinical utility in diagnosing coronary disease. Circulation 1984; 69: 541-7
  5. Melin JA, Wijns W, Vanbutsele RJ, Robert A, De Coster P, Brasseur LA, et al. Alternative diagnostic strategies for coronary artery disease in women: demonstration of the usefulness and efficiency of probability analysis. Circulation 1985; 71: 535-42
  6. Rutherford JD. Cardiology Core Curriculum, A problem-based approach. London: BMJ Books; 2003
  7. Taegtmeyer H. From fetal to fatal metabolic adaptation of the heart to environmental stress. In: Cokkinos DV, Patnos C, Heush G, Taegtmeyer H, editors. Myocardial ischemia from mechanism to therapeutic potential. USA: Springer; 2006. p.11-4
  8. Johansen A, Hoilund-Carlsen PF, Christensen HW, Grupe P, Veje A, Vach W, et al. Observer variability in the evaluation of dual-isotope Tl-201/Tc-99m sestamibi rest/stress myocardial perfusion SPECT in men and women with known or suspected stable angina pectoris. J Nucl Cardiol 2004; 11: 710-8
  9. Strauss HW, Miller DD, Wittry MD, Cerquerica MD, Garcia EV, Iskandrian AS, et al. Procedure guideline for myocardial perfusion imaging 3.3. J Nucl Med Technol 2008; 36: 155-61
  10. Hesse B, Tagil K, Cuoccolo A, Anagnostopoulos C, Bardies M, Bax J, et al. EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology. Eur J Nucl Med Mol Imaging 2005; 32: 855-97
  11. Diamond GA, Forrester JS,